These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 750110)

  • 61. Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).
    Bodell WJ; Bodell AP; Giannini DD
    Neuro Oncol; 2007 Jan; 9(1):12-9. PubMed ID: 17018699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
    Zackheim HS; Smuckler EA
    Experientia; 1980 Oct; 36(10):1211-2. PubMed ID: 7418808
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracerebral chemotherapy in the 9L rat brain tumor model.
    Kimler BF; Liu C; Evans RG; Morantz RA
    J Neurooncol; 1992 Nov; 14(3):191-200. PubMed ID: 1281224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of 11C-BCNU in experimental brain tumor.
    Sako K; Diksic M; Farrokhzad S; Yamamoto YL; Feindel W
    J Neurooncol; 1985; 3(3):229-35. PubMed ID: 4056852
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
    J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Hoshino T; Barker M; Deen DF
    Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A toxicologic comparison of the potency and activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in mice and rats.
    Thompson GR; Larson RE
    Toxicol Appl Pharmacol; 1972 Mar; 21(3):405-13. PubMed ID: 5027972
    [No Abstract]   [Full Text] [Related]  

  • 70. Distribution of 14C after topical application of 14C-labeled 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in mice.
    Zackheim HS; Feldmann RJ; Lindsay C; Maibach HI
    Experientia; 1977 Jun; 33(6):753-4. PubMed ID: 891737
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The chemotherapy of tumors of the central nervous system (author's transl)].
    Paoletti P
    Riv Patol Nerv Ment; 1976; 96(1):19-34. PubMed ID: 183261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain.
    Fung LK; Shin M; Tyler B; Brem H; Saltzman WM
    Pharm Res; 1996 May; 13(5):671-82. PubMed ID: 8860421
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemical stability, alkylating activity, and lipophilicity of 1,1'-ethylene-bis(1-nitrosourea) and related compounds.
    Morimoto K; Yamaha T; Nakadate M; Suzuki I
    Gan; 1978 Feb; 69(1):139-42. PubMed ID: 640322
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
    Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
    J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine.
    Bodell WJ; Morgan WF; Rasmussen J; Williams ME; Deen DF
    Biochem Pharmacol; 1985 Feb; 34(4):515-20. PubMed ID: 3970721
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
    Lee FY; Workman P
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1627-30. PubMed ID: 6237080
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intraarterial O6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Kurpad SN; Dolan ME; McLendon RE; Archer GE; Moschel RC; Pegg AE; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 1997; 39(4):307-16. PubMed ID: 9025771
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DNA damage in the intracerebral rat gliosarcoma 9L treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Gutin PH; Hilton J; Fein VJ; Allan AE; Rottman A; Walker MD
    Cancer Res; 1977 Oct; 37(10):3761-5. PubMed ID: 908019
    [No Abstract]   [Full Text] [Related]  

  • 80. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.